RESUMEN
INTRODUCTION AND OBJECTIVES: Atopic dermatitis is a chronic, relapsing, highly pruritic, inflammatory skin disease characterized by typical localization with increasing prevalence of 10-20% in children. Pruritus is one of the major diagnostic criteria of atopic dermatitis and also the main complaint altering quality-of-life of affected patients, inducing and aggravating inflammation. Although pruritus is the absolute symptom of AD, the etiology has not been fully explained yet and current antihistamine therapies are ineffective. The aim of the study was to assess the correlation between IL-31 level and disease severity in patients with atopic dermatitis through Severity SCORing of Atopic Dermatitis (SCORAD) index and the degree of itching assessed subjectively. MATERIAL AND METHODS: One hundred thirty-five children were enrolled in the study in total, 70 children with diagnosis of atopic dermatitis and 65 healthy children in control group. Data on demographic features (age, gender, family history of atopy) and laboratory values of serum eosinophil, total IgE, IgM, IgA, IgG levels and skin prick test results were collected through patient files. The disease severity was assessed by SCORAD index. IL-31 levels were measured with human IL-31 ELISA kit. RESULTS: The statistical analysis showed that IL-31 level was significantly higher in AD patients than in the control group (AD vs CG, p 0.0001). There was no significant difference in IL-31 levels between the three subgroups divided according to the SCORAD severity score (p:0.27). CONCLUSION: IL-31 levels were significantly higher in AD patients compared to control group but irrelevant to the disease severity
No disponible
Asunto(s)
Humanos , Masculino , Femenino , Preescolar , Niño , Dermatitis Atópica/inmunología , Interleucinas/inmunología , Dermatitis Atópica/complicaciones , Interleucinas/sangre , Prurito/sangre , Prurito/etiología , Índice de Severidad de la EnfermedadRESUMEN
INTRODUCTION AND OBJECTIVES: Atopic dermatitis is a chronic, relapsing, highly pruritic, inflammatory skin disease characterized by typical localization with increasing prevalence of 10-20% in children. Pruritus is one of the major diagnostic criteria of atopic dermatitis and also the main complaint altering quality-of-life of affected patients, inducing and aggravating inflammation. Although pruritus is the absolute symptom of AD, the etiology has not been fully explained yet and current antihistamine therapies are ineffective. The aim of the study was to assess the correlation between IL-31 level and disease severity in patients with atopic dermatitis through Severity SCORing of Atopic Dermatitis (SCORAD) index and the degree of itching assessed subjectively. MATERIAL AND METHODS: One hundred thirty-five children were enrolled in the study in total, 70 children with diagnosis of atopic dermatitis and 65 healthy children in control group. Data on demographic features (age, gender, family history of atopy) and laboratory values of serum eosinophil, total IgE, IgM, IgA, IgG levels and skin prick test results were collected through patient files. The disease severity was assessed by SCORAD index. IL-31 levels were measured with human IL-31 ELISA kit. RESULTS: The statistical analysis showed that IL-31 level was significantly higher in AD patients than in the control group (AD vs CG, p 0.0001). There was no significant difference in IL-31 levels between the three subgroups divided according to the SCORAD severity score (p:0.27). CONCLUSION: IL-31 levels were significantly higher in AD patients compared to control group but irrelevant to the disease severity.
Asunto(s)
Dermatitis Atópica/inmunología , Interleucinas/inmunología , Niño , Preescolar , Dermatitis Atópica/sangre , Dermatitis Atópica/complicaciones , Femenino , Humanos , Interleucinas/sangre , Masculino , Prurito/sangre , Prurito/inmunología , Índice de Severidad de la EnfermedadRESUMEN
Of 405 patients with stage IV transitional cell carcinoma from an international multicenter phase III trial, 70 were randomized in Germany to receive either gemcitabine/cisplatin or standard MVAC systemic chemotherapy for locally advanced or metastatic urothelial cancer. Overall survival as the primary endpoint of the study was similar in both arms (median survival GC 15.4 months vs MVAC 16.1 months), as were tumor-specific survival and time to progressive disease. In the intent-to-treat analysis, the 5-year overall survival rate was 10% for patients randomized to GC and 18% randomized to MVAC. Tumor overall response rates (GC 54%, MVAC 53%) were similar. The toxic death rate was 0% in the GC arm and 3% (one patient) in the MVAC arm. Significantly more GC than MVAC patients experienced grade 3/4 anemia (GC 52%, MVAC 20%) with significantly more red blood cell transfusions in the GC arm.Significantly more GC than MVAC patients had grade 3/4 thrombocytopenia (GC 54%, MVAC 17%) without grade 3/4 hemorrhage or hematuria in either arm. More MVAC patients experienced grade 3/4 neutropenia (GC 56%, MVAC 61%, p=1.000), neutropenic or leukopenic fever (GC 0%, MVAC 10%, p=0.237), mucositis (GC 0%, MVAC 7%, p=0.495), and alopecia (GC 6%, MVAC 36%, p=0.004). GC represents a reasonable alternative for the palliative treatment of patients with locally advanced and metastatic transitional cell carcinoma. Sustained long-term survival was only found for patients with locally advanced cancer, lymphatic metastases, or solitary distant metastasis but not for visceral metastatic disease.
Asunto(s)
Protocolos de Quimioterapia Combinada Antineoplásica/administración & dosificación , Protocolos de Quimioterapia Combinada Antineoplásica/uso terapéutico , Carcinoma de Células Transicionales/tratamiento farmacológico , Cisplatino/administración & dosificación , Desoxicitidina/análogos & derivados , Desoxicitidina/administración & dosificación , Doxorrubicina/administración & dosificación , Metotrexato/administración & dosificación , Cuidados Paliativos , Neoplasias Urológicas/tratamiento farmacológico , Vinblastina/administración & dosificación , Adulto , Anciano , Protocolos de Quimioterapia Combinada Antineoplásica/efectos adversos , Carcinoma de Células Transicionales/mortalidad , Carcinoma de Células Transicionales/patología , Cisplatino/efectos adversos , Desoxicitidina/efectos adversos , Progresión de la Enfermedad , Doxorrubicina/efectos adversos , Femenino , Estudios de Seguimiento , Humanos , Metástasis Linfática/patología , Masculino , Metotrexato/efectos adversos , Persona de Mediana Edad , Estadificación de Neoplasias , Estudios Prospectivos , Tasa de Supervivencia , Neoplasias Urológicas/mortalidad , Neoplasias Urológicas/patología , Vinblastina/efectos adversos , GemcitabinaAsunto(s)
Enfermedades de la Coroides/tratamiento farmacológico , Pentamidina/uso terapéutico , Neumonía por Pneumocystis/tratamiento farmacológico , Síndrome de Inmunodeficiencia Adquirida/complicaciones , Administración por Inhalación , Adulto , Enfermedades de la Coroides/complicaciones , Enfermedades de la Coroides/microbiología , Femenino , Humanos , Pentamidina/administración & dosificación , Pneumocystis/efectos de los fármacos , Neumonía por Pneumocystis/complicaciones , Agudeza Visual , Zidovudina/uso terapéuticoRESUMEN
Retroperitoneal abscesses have been a difficult diagnostic and therapeutic challenge in the past. With the advent of precise noninvasive imaging modalities, they now are defined more easily. Percutaneous guided catheter drainage has changed our therapeutic approach to this disease and enabled rapid and complete drainage to be performed in the majority of cases. Although the literature is replete with documentation of the percutaneous management of intra-abdominal abscesses, series dealing with retroperitoneal abscesses exclusively are surprisingly infrequent. We report on the percutaneous treatment of 31 retroperitoneal abscesses and the combined percutaneous and surgical management of 4 additional cases.
Asunto(s)
Absceso/terapia , Drenaje/métodos , Punciones , Espacio Retroperitoneal , Absceso/diagnóstico , Adolescente , Adulto , Anciano , Anciano de 80 o más Años , Cateterismo/métodos , Drenaje/efectos adversos , Femenino , Humanos , Masculino , Persona de Mediana Edad , Punciones/efectos adversos , Espacio Retroperitoneal/diagnóstico por imagen , Tomografía Computarizada por Rayos X , UltrasonografíaRESUMEN
Cervical esophageal varices occur rarely. Although cases of primary upper esophageal varices have been reported, the most frequent underlying etiology is superior vena cava obstruction. Usually asymptomatic, cervical esophageal varices may occasionally be responsible for significant gastrointestinal hemorrhage. Twenty-five cases of upper esophageal varices have been described in the literature to date. Three additional cases are presented and the previous literature is reviewed. Potential collateral pathways in the presence of superior vena cava obstruction are discussed.
Asunto(s)
Várices Esofágicas y Gástricas/diagnóstico por imagen , Vena Cava Superior/diagnóstico por imagen , Adolescente , Carcinoma Broncogénico/complicaciones , Constricción Patológica , Várices Esofágicas y Gástricas/etiología , Hemorragia Gastrointestinal/etiología , Humanos , Neoplasias Pulmonares/complicaciones , Masculino , Persona de Mediana Edad , RadiografíaRESUMEN
Nineteen patients with 20 axillary-subclavian vein thromboses were examined by venography. In 70% the axillary and subclavian veins were involved in continuity. The innominate vein was seldom involved, although demonstration of this was difficult. In 50% of the patients the thrombosis was a secondary phenomenon associated with either breast carcinoma, central venous pressure lines, heroin addiction, or cervical rib.
Asunto(s)
Vena Axilar/diagnóstico por imagen , Vena Subclavia/diagnóstico por imagen , Tromboflebitis/diagnóstico por imagen , Venas Braquiocefálicas/diagnóstico por imagen , Neoplasias de la Mama/complicaciones , Femenino , Humanos , Masculino , Esfuerzo Físico , Radiografía , Tromboflebitis/etiologíaRESUMEN
1. When pancreatic islets are preincubated for 20h in the presence of glucose (83.3mM) and thereafter transferred to a glucose-free medium, theophylline (1.4mM) provokes a dramatic stimulation of insulin release. This phenomenon does not occur when the islets are preincubated for either 20h at low glucose concentration (5.6mM) or only 30 min at the high glucose concentration (83.3mM). 2. The insulinotropic action of theophylline cannot be attributed to contamination of the islets with exogenous glucose and is not suppressed by mannoheptulose. 3. The secretory response to theophylline is an immediate phenomenon, but disappears after 60min of exposure to the drug. 4. The release of insulin evoked by theophylline is abolished in calcium-depleted media containing EGTA. Theophylline enhances the net uptake of 45Ca by the islets. 5. Glycogen accumulates in the islets during the preincubation period, as judged by both ultrastructural and biochemical criteria. Theophylline significantly increases the rate of glycogenolysis during the final incubation in the glucose-free medium. 6. The theophylline-induced increase in glycogenolysis coincides with a higher rate of both lactate output and oxidation of endogenous 14C-labelled substrates. 7. These data suggest that stimulation of glycolysis from endogenous stores of glycogen is sufficient to provoke insulin release even in glucose-deprived islets, as if the binding of extracellular glucose to hypothetical plasma-membrane glucoreceptors is not an essential feature of the stimulus-secretion coupling process.
Asunto(s)
Glucógeno/metabolismo , Insulina/metabolismo , Islotes Pancreáticos/metabolismo , Animales , Calcio/metabolismo , Glucosa/metabolismo , Glucógeno/análisis , Glucólisis/efectos de los fármacos , Técnicas In Vitro , Secreción de Insulina , Islotes Pancreáticos/ultraestructura , Ratas , Teofilina/farmacologíaRESUMEN
Alpha-D-Glucose is known to exert more marked insulinotropic action than B-D-glucose. Both anomers are phosphorylated at the same rate by rat islet homogenates. The islet glucose-6-phosphate dehydrogenase displays a preferential affinity towards beta-D-glucose-6-phosphate, and this coincides with a higher sorbitol content in the islets exposed to beta-D-glucose. On the contrary, the islet phosphoglucose isomerase is stereospecific for alpha-D-glucose 6-phosphate and, hence, the concentration of glucose 6-phosphate is lower and that of the alpha-anomer to lactate and CO2 is also higher than that of beta-D-glucose. This increased glycolytic flux is associated with a more marked inhibitory action on 14Ca efflux, a more pronounced stimulation of 45Ca net uptake and a higher rate of insulin release in the islets exposed to alpha-D-glucose. The more marked insulinotropic action of alpha- as a distinct from beta-D-glucose is thus compatible with the view that glycolysis represents the key component of the sensor device through which glucose is identified in the pancreatic B-cell as a stimulus for insulin release.